Molecular imaging as a de-risking tool: coming into focus?

Nat Rev Drug Discov. 2013 Apr;12(4):251-2. doi: 10.1038/nrd3993.
No abstract available

Publication types

  • News

MeSH terms

  • Central Nervous System Agents / pharmacokinetics*
  • Central Nervous System Agents / pharmacology
  • Central Nervous System Diseases / drug therapy
  • Clinical Trials as Topic / methods
  • Drug Design*
  • Drug Industry / methods
  • Humans
  • Molecular Imaging / methods*
  • Tissue Distribution

Substances

  • Central Nervous System Agents